181 related articles for article (PubMed ID: 23116442)
1. Antimicrobial peptide rBPI21: a translational overview from bench to clinical studies.
Domingues MM; Santos NC; Castanho MA
Curr Protein Pept Sci; 2012 Nov; 13(7):611-9. PubMed ID: 23116442
[TBL] [Abstract][Full Text] [Related]
2. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
3. rBPI21 interacts with negative membranes endothermically promoting the formation of rigid multilamellar structures.
Domingues MM; Bianconi ML; Barbosa LR; Santiago PS; Tabak M; Castanho MA; Itri R; Santos NC
Biochim Biophys Acta; 2013 Nov; 1828(11):2419-27. PubMed ID: 23792068
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria.
Wiese A; Brandenburg K; Carroll SF; Rietschel ET; Seydel U
Biochemistry; 1997 Aug; 36(33):10311-9. PubMed ID: 9254630
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial protein rBPI21-induced surface changes on Gram-negative and Gram-positive bacteria.
Domingues MM; Silva PM; Franquelim HG; Carvalho FA; Castanho MA; Santos NC
Nanomedicine; 2014 Apr; 10(3):543-51. PubMed ID: 24262996
[TBL] [Abstract][Full Text] [Related]
6. rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes.
Domingues MM; Castanho MA; Santos NC
PLoS One; 2009 Dec; 4(12):e8385. PubMed ID: 20027298
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of membrane targeting antibiotics.
Epand RM; Walker C; Epand RF; Magarvey NA
Biochim Biophys Acta; 2016 May; 1858(5):980-7. PubMed ID: 26514603
[TBL] [Abstract][Full Text] [Related]
8. Topomimetics of amphipathic beta-sheet and helix-forming bactericidal peptides neutralize lipopolysaccharide endotoxins.
Chen X; Dings RP; Nesmelova I; Debbert S; Haseman JR; Maxwell J; Hoye TR; Mayo KH
J Med Chem; 2006 Dec; 49(26):7754-65. PubMed ID: 17181157
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
10. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
[TBL] [Abstract][Full Text] [Related]
11. De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs.
Bhattacharjya S
Curr Med Chem; 2010; 17(27):3080-93. PubMed ID: 20629624
[TBL] [Abstract][Full Text] [Related]
12. The bactericidal/permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo.
Elsbach P; Weiss J; Doerfler M; Shu C; Kohn F; Ammons WS; Kung AH; Meszaros KK; Parent JB
Prog Clin Biol Res; 1994; 388():41-51. PubMed ID: 7831373
[TBL] [Abstract][Full Text] [Related]
13. NMR Structures and Interactions of Antimicrobial Peptides with Lipopolysaccharide: Connecting Structures to Functions.
Bhattacharjya S
Curr Top Med Chem; 2016; 16(1):4-15. PubMed ID: 26139110
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
[TBL] [Abstract][Full Text] [Related]
15. Designing potent antimicrobial peptides by disulphide linked dimerization and N-terminal lipidation to increase antimicrobial activity and membrane perturbation: Structural insights into lipopolysaccharide binding.
Datta A; Kundu P; Bhunia A
J Colloid Interface Sci; 2016 Jan; 461():335-345. PubMed ID: 26407061
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates.
Wiese A; Brandenburg K; Lindner B; Schromm AB; Carroll SF; Rietschel ET; Seydel U
Biochemistry; 1997 Aug; 36(33):10301-10. PubMed ID: 9254629
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of the bactericidal/permeability-increasing protein.
Levy O
Expert Opin Investig Drugs; 2002 Feb; 11(2):159-67. PubMed ID: 11829710
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of neonatal innate defense: effects of adding an N-terminal recombinant fragment of bactericidal/permeability-increasing protein on growth and tumor necrosis factor-inducing activity of gram-negative bacteria tested in neonatal cord blood ex vivo.
Levy O; Sisson RB; Kenyon J; Eichenwald E; Macone AB; Goldmann D
Infect Immun; 2000 Sep; 68(9):5120-5. PubMed ID: 10948134
[TBL] [Abstract][Full Text] [Related]
19. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
[TBL] [Abstract][Full Text] [Related]
20. Peptides with dual mode of action: Killing bacteria and preventing endotoxin-induced sepsis.
Brandenburg K; Heinbockel L; Correa W; Lohner K
Biochim Biophys Acta; 2016 May; 1858(5):971-9. PubMed ID: 26801369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
